Sitting on the FENSA: WHO engagement with industry

The Lancet

Volumn 388, Issue 10043, 2016, Pages 446-447

  Buse, Kent ^a   Hawkes, Sarah ^b  

^a UNAIDS   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPTUAL FRAMEWORK; FRAMEWORK OF ENGAGEMENT WITH NON STATE ACTOR; HEALTH CARE INDUSTRY; HUMAN; NOTE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; CONFLICT OF INTEREST; ETHICS; INDUSTRY; ORGANIZATION AND MANAGEMENT; POLICY;

CONFLICT OF INTEREST; HUMANS; INDUSTRY; PRIVATE SECTOR; PUBLIC POLICY; PUBLIC SECTOR; WORLD HEALTH ORGANIZATION;

EID: 84989184583     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31141-2     Document Type: Note

References (13)

1. Bexell, M, Tallberg, J, Uhlin, A, Democracy in global governance: the promises and pitfalls of transnational actors. Global Governance 16 (2010), 81–101.
2. WHO. Framework of engagement with non-State actors. Sixty-ninth World Health Assembly, Agenda Item 11.3, 2016, World Health Organization, Geneva http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_ACONF11-en.pdf (accessed June 30, 2016).
3. Lhotská, L, Gupta, A, Whose health? The crucial negotiations over the World Health Organization's future, May 19, 2016, Asia & the Pacific Policy Society http://www.policyforum.net/whose-health/ (accessed June 29, 2016).
4. International Federation of Pharmaceutical Manufacturers Associations. WHA 69, item 11.3 Framework of engagement with non-State actors. Statement from International Federation of Pharmaceutical Manufacturers Associations. http://www.ifpma.org/wp-content/uploads/2016/05/IFPMA-Statement-11.3-NSA-May-2016-final.pdf, May, 2016 (accessed June 29, 2016).
5. Wilson, D, Kerlin, A, Special report: food, beverage industry pays for seat at health-policy table. Reuters. http://www.reuters.com/article/2012/10/19/us-obesity-who-industry-idUSBRE89I0K620121019, Oct 19, 2012 (accessed June 30, 2016).
6. Third World Network. WHO: unease over seconded philanthropic foundation staff to top management, December, 2015, Third World Network http://www.twn.my/title2/health.info/2015/hi151202.htm (accessed June 29, 2016).
7. Stuckler, D, Basu, S, McKee, M, Global health philanthropy and institutional relationships: how should conflicts of interest be addressed?. PLoS Med, 8, 2011, e1001020.
8. Stuckler, D, Nestle, M, Big food, food systems, and global health. PLoS Med, 9, 2012, e1001242.
9. Beaglehole, R, Bonita, R, Horton, R, et al., for the Lancet NCD Action Group and the NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet 377 (2011), 1438–1447.
10. WHO. Global action plan for the prevention and control of NCDs, 2013–2020, 2013, World Health Organization.
11. Buse, K, Naylor, C, Commercial health governance. Buse, K, Hein, W, Drager, N, (eds.) Making sense of global health governance, 2009, Palgrave Macmillan, London, 187–208.
12. Faculty of Public Health, UK. FPH withdraws from responsibility deals. http://www.fph.org.uk/fph_withdraws_from_responsibility_deals, July 15, 2013 (accessed June 29, 2016).
13. Abbott, K, Snidal, D, Taking responsive regulation transnational: strategies for international organizations. Regulation and Governance, 7, 2013, 96.